Lacosamide efficasy and safety on pain in patients with multiple sclerosis: A randomized double_blind clinical trial - Trial IRCT20190804044429N8
Access comprehensive clinical trial information for IRCT20190804044429N8 through Pure Global AI's free database. This Phase 3 trial is sponsored by Mazandaran University of Medical Sciences and is currently Recruiting. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20190804044429N8
Phase 3
Recruiting
Trial Details
Iranian Registry Of Clinical Trial • IRCT20190804044429N8
Lacosamide efficasy and safety on pain in patients with multiple sclerosis: A randomized double_blind clinical trial
Study Focus
Interventional
Sponsor & Location
Mazandaran University of Medical Sciences
Iran
Timeline & Enrollment
Phase 3
Sep 23, 2022
N/A
ICD-10 Classifications
Multiple sclerosis
Progressive systemic sclerosis
Systemic sclerosis
Systemic sclerosis, unspecified
Diffuse sclerosis
Data Source
Iranian Registry Of Clinical Trial
IRCT20190804044429N8
Non-Device Trial